Tricida, Inc. Gains 28.83%
Fri 30 Oct 20 at 05:30 PM
Tricida, Inc. (TCDA:NASDAQ) rocketted at $5.63, representing a gain of 28.8%. On Thu 29 Oct 20, TCDA:NASDAQ hit a New 2-Week Low of $4.37. The stock got featured on our News Catalysts scanner on Thu 29 Oct 20 at 07:21 PM in the 'INVESTOR UPDATE' category. From Thu 15 Oct 20, the stock recorded 40.00% Up Days and 36.36% Green Days
About Tricida, Inc. (TCDA:NASDAQ)
Tricida Inc is a late-stage pharmaceutical company. It is engaged in the development of novel therapeutics to address renal, metabolic and cardiovascular disease. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Top 10 Gainers:
- BioLineRx Ltd. (BLRX:NASDAQ), 33.78%
- Tricida, Inc. (TCDA:NASDAQ), 28.83%
- Air Industries Group (AIRI:NYSEMKT), 27.82%
- Daseke, Inc. (DSKE:NASDAQ), 26.59%
- Build-A-Bear Workshop, Inc. (BBW:NYSE), 24.4%
- Acadia Healthcare Company, Inc. (ACHC:NASDAQ), 23.02%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.22%
- MICT, Inc. (MICT:NASDAQ), 21.88%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 21.76%
- LNSR (LNSR:NASDAQ), 19.61%